FI860967A0 - Fetma motverkande medel. - Google Patents

Fetma motverkande medel.

Info

Publication number
FI860967A0
FI860967A0 FI860967A FI860967A FI860967A0 FI 860967 A0 FI860967 A0 FI 860967A0 FI 860967 A FI860967 A FI 860967A FI 860967 A FI860967 A FI 860967A FI 860967 A0 FI860967 A0 FI 860967A0
Authority
FI
Finland
Prior art keywords
inhibitor
alpha
motverkande
fetma
medel
Prior art date
Application number
FI860967A
Other languages
English (en)
Other versions
FI860967A (fi
Inventor
Takao Matsuo
Satoshi Horii
Nobuyuki Kitamori
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1985/000118 external-priority patent/WO1986005094A1/ja
Priority claimed from PCT/JP1985/000246 external-priority patent/WO1986006276A1/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FI860967A0 publication Critical patent/FI860967A0/fi
Publication of FI860967A publication Critical patent/FI860967A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI860967A 1985-03-08 1986-03-07 Fetma motverkande medel. FI860967A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP1985/000118 WO1986005094A1 (en) 1985-03-08 1985-03-08 Antiobesity agent and composition
PCT/JP1985/000246 WO1986006276A1 (en) 1985-04-30 1985-04-30 Sugar digestion-restraining agent and sugar digestion-restraining composition

Publications (2)

Publication Number Publication Date
FI860967A0 true FI860967A0 (fi) 1986-03-07
FI860967A FI860967A (fi) 1986-09-09

Family

ID=26425971

Family Applications (1)

Application Number Title Priority Date Filing Date
FI860967A FI860967A (fi) 1985-03-08 1986-03-07 Fetma motverkande medel.

Country Status (7)

Country Link
EP (1) EP0194794A3 (fi)
JP (1) JPH072647B2 (fi)
AU (1) AU596961B2 (fi)
CA (1) CA1255591A (fi)
DK (1) DK97986A (fi)
FI (1) FI860967A (fi)
NO (1) NO165662C (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61205455A (ja) * 1985-03-11 1986-09-11 Takeda Chem Ind Ltd 低カロリ−砂糖含有組成物
ATE86853T1 (de) * 1988-08-22 1993-04-15 Takeda Chemical Industries Ltd Alpha-glucosidaseinhibitor zur foerderung der calciumabsorption.
US7097845B2 (en) * 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
CA2300211A1 (en) * 1997-08-27 1999-03-04 Masato Iwasaki Sustained-release oral preparation
JP2001523704A (ja) * 1997-11-25 2001-11-27 バイエル・アクチエンゲゼルシヤフト α−グルコシダーゼ阻害剤を含んで成る持続放出性製剤
JP4580542B2 (ja) * 2000-05-17 2010-11-17 株式會社バイオニア 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物
US7022684B2 (en) 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
MY176503A (en) * 2009-03-26 2020-08-12 Biofermin Pharmaceutical Co Ltd Hypoglycemic effect enhancer
WO2012011174A1 (ja) * 2010-07-22 2012-01-26 ビオフェルミン製薬株式会社 脂質代謝改善剤、脂質代謝改善作用増強剤、抗肥満剤及び抗肥満作用増強剤
WO2013081563A2 (en) * 2011-10-24 2013-06-06 Mahmut Bilgic Stable tablet formulations
KR101697260B1 (ko) * 2015-07-27 2017-01-17 고려대학교 산학협력단 보글리보즈를 유효성분으로 함유하는 비만 개선, 정장 또는 장내 균총 개선용 조성물
JP2020184909A (ja) * 2019-05-13 2020-11-19 学校法人帝京大学 血糖降下剤、及び、該血糖降下剤を含有する飲食品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7012090A (en) * 1970-08-17 1972-02-21 Bifidogen complex
EP0056194B1 (en) * 1981-01-05 1984-09-12 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars, their production and use
EP0075604A1 (en) * 1981-09-24 1983-04-06 Asahi Kasei Kogyo Kabushiki Kaisha Blood glucose level-lowering agent

Also Published As

Publication number Publication date
EP0194794A3 (en) 1986-12-17
JPS61205215A (ja) 1986-09-11
FI860967A (fi) 1986-09-09
NO165662B (no) 1990-12-10
CA1255591A (en) 1989-06-13
EP0194794A2 (en) 1986-09-17
AU5427186A (en) 1986-09-11
DK97986A (da) 1986-09-09
AU596961B2 (en) 1990-05-24
DK97986D0 (da) 1986-03-04
NO165662C (no) 1991-03-20
NO860826L (no) 1986-09-09
JPH072647B2 (ja) 1995-01-18

Similar Documents

Publication Publication Date Title
FI860967A (fi) Fetma motverkande medel.
DE69122099D1 (de) Zusammensetzung und verfahren zur prävention und behandlung von hypercholesterinämie und zellproliferationsstorungen
IL153989A (en) Nutritional composition comprising mixture of functional carbohydrates
ZA926241B (en) Dosage form for delivering drug in short-time period
FR2604090B1 (fr) Forme de dosage pharmaceutique solide comprenant au moins une unite a liberation controlee
ATE67666T1 (de) Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.
IT1176916B (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
GR861803B (en) Novel carbonic acid derivatives method for their preparation their use and medicine containing them
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
NO20010892L (no) Naturlig, fysiologisk aktivt materiale som er virksomt mot fiskesykdommer, og fiskefor inneholdende materialet
KR930021178A (ko) 뼈 형성을 자극하는 약제
DE58903919D1 (en) Propanolaminderivate.
DE3875637D1 (de) Zusammensetzungen und verfahren zur behandlung von magengeschwueren.
DK0402208T3 (da) Sammensætning af vitamin A i fysiologisk dosis og forskellige aktive bestanddele med en terapeutisk aktivitet
ATE212229T1 (de) Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden
NO982635D0 (no) Sammensetninger inneholdende vismut og ett eller flere antimikrobielle midler for forebygging og behandling av gastrointestinale forstyrrelser
TR199801021T2 (xx) Mide-ba��rsak bozukluklar�n�n �nlenmesi ve tedavisi i�in bizmut i�eren bile�imler.
TH32073A (th) กรรมวิธีสำหรับการป้องกันและรักษาอาการผิดปกติที่เกี่ยวข้องกับระบบกระเพาะอาหารและลำใส้
IT1190194B (it) Combinazione di analgesico centrale ed adenina per il trattamento analgesico del corpo umano o animale e composizione farmaceutica che la contiene
TH32208A (th) วิธีและสารผสมสำหรับการป้องกันและการรักษาอาการผิดปกติของกระเพาะอาหารและลำใส้
ATE211914T1 (de) Wismuth enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden
KR960028837A (ko) 신선초를 주원료로 하는 액체 엑기스 건강식품
RU94041584A (ru) Способ лечения язвенной болезни

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: TAKEDA CHEMICAL INDUSTRIES, LTD.